The MGH Depression Clinical & Research Program (DCRP) is considered one of the leading centers for the study of Unipolar Depressive Disorders worldwide.
The ongoing work of the Depression Clinical and Research Program has, in many cases, defined Depression treatments for the field. Over the years a large group of experienced researchers as well as promising young trainees and junior faculty have gathered, generating countless clinical reports, pilot studies, and large controlled trials. The staff at the DCRP have successfully obtained significant funding from both the National Institute of Mental Health and industry sources. Currently, there are more than 20 ongoing studies at the DCRP.
The DCRP is currently conducting cutting edge research in the area of depression, with a focus on testing novel antidepressant treatments and on developing new tools to understand the biological changes that occur in this condition
U.S. News & World Report ranks Mass General psychiatry second among U.S. hospitals.
Discover the largest hospital-based research program in the U.S. and how clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and bring the latest advances to patient care
When you support the Department of Psychiatry, you are making a significant contribution to advancing care at the hospital.